MONOAMINE-OXIDASE INHIBITORS - SAFETY AND EFFICACY ISSUES

被引：20

作者：

BROWN, CS ^{[1
]}

BRYANT, SG ^{[1
]}

机构：

[1] UNIV TEXAS,MED BRANCH,DEPT PSYCHIAT & BEHAV SCI,GALVESTON,TX 77550

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1988年 / 22卷 / 03期

关键词：

D O I：

10.1177/106002808802200311

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：232 / 235

页数：4

共 23 条

[11]

MCGRATH PJ, 1986, J CLIN PSYCHIAT, V47, P420

[12]

MURPHY DL, 1984, PSYCHIAT CLIN N AM, V7, P549

[13]

NEIL JF, 1979, J CLIN PSYCHIAT, V40, P33

[14]

NIES A, 1984, J CLIN PSYCHIAT, V45, P70

[15]

QUITKIN F, 1979, ARCH GEN PSYCHIAT, V36, P749

[16]

RABKIN J, 1984, J CLIN PSYCHOPHARM, V4, P270

RAFT, D ;

DAVIDSON, J ;

WASIK, J ;

MATTOX, A .

[18]

RASKIN A, 1974, ARCH GEN PSYCHIAT, V30, P66

[19]

ROBINSON DS, 1985, PSYCHOPHARMACOL BULL, V21, P562

ROWAN, PR ;

PAYKEL, ES ;

PARKER, RR .